Details

Likes
0
Followers
0
Directory
Cancer

Expertise

biomedicine cancer biology EUTROC ovarian cancer ovarian cancer biomarkers




Sponsored

Jaume Reventos

Director, Bellvitge Biomedical Research Institute (IDIBELL), University of Barcelona, Spain

  • Institut d’Investigació Biomèdica de Bellvitge, Hospital Duran i Reynals, Av Gran Via de l’Hospitalet 199 – 203, 08907 l’Hospitalet de Llobregat, Barcelona,Spain


10 years, 4 months ago

What are the implications of the absence of standard pathways for diagnostics and imaging biomarkers?

Jaume Reventos
Directory:
Cancer
Tags:
biomarkers
DNA sequencing
EUTROC
fibroblasts
genetic mutations
genomics
ovarian cancer
personalized medicine
proteonomics
translational research
Play
Current Time 0:00
/
Duration Time 0:00
Remaining Time -0:00
Loaded: 0%
Progress: 0%
00:00
Fullscreen
00:00
Mute
view in full page
10 years, 5 months ago

What is EUTROC and why is it important?

Jaume Reventos
Directory:
Cancer
Tags:
biobanks
EUTROC
molecular targets
ovarian cancer
personalized medicine
tissue samples
translational research
tumor banks
tumor profiling
virtual tumor banks
Play
Current Time 0:00
/
Duration Time 0:00
Remaining Time -0:00
Loaded: 0%
Progress: 0%
00:00
Fullscreen
00:00
Mute
view in full page
10 years, 5 months ago

What new strategies are there in ovarian cancer translational research?

Jaume Reventos
Directory:
Cancer
Tags:
biobanks
EUTROC
genetic targets
molecular targets
ovarian cancer
personalized medicine
tissue samples
translational research
tumor banks
tumor profiling
Play
Current Time 0:00
/
Duration Time 0:00
Remaining Time -0:00
Loaded: 0%
Progress: 0%
00:00
Fullscreen
00:00
Mute
view in full page
10 years, 5 months ago

What is translational medicine?

Jaume Reventos
Directory:
Cancer
Tags:
biobanks
EUTROC
genetic targets
molecular targets
ovarian cancer
personalized medicine
tissue samples
translational research
tumor banks
tumor profiling
Play
Current Time 0:00
/
Duration Time 0:00
Remaining Time -0:00
Loaded: 0%
Progress: 0%
00:00
Fullscreen
00:00
Mute
view in full page
10 years, 5 months ago

How effective is data sharing across different medical institutions, communities, and contexts?

Jaume Reventos
Directory:
Cancer
Tags:
disposal
EUTROC
molecular targets
ovarian cancer
personalized medicine
privacy
tissue samples
translational research
tumor banks
tumor profiling
Play
Current Time 0:00
/
Duration Time 0:00
Remaining Time -0:00
Loaded: 0%
Progress: 0%
00:00
Fullscreen
00:00
Mute
view in full page
10 years, 5 months ago

Why is personalised medicine important?

Jaume Reventos
Directory:
Cancer
Tags:
biobanks
EUTROC
genetic targets
molecular targets
ovarian cancer
personalized medicine
tissue samples
translational research
tumor banks
tumor profiling
Play
Current Time 0:00
/
Duration Time 0:00
Remaining Time -0:00
Loaded: 0%
Progress: 0%
00:00
Fullscreen
00:00
Mute
view in full page
10 years, 6 months ago

What would you recommend that a patient knows about clinical studies?

Jaume Reventos
Directory:
Cancer
Tags:
cancer
chemotherapy
clinical trial
EUTROC
informed consent
ovarian cancer
personalized medicine
safety
sponsor
translational research
Play
Current Time 0:00
/
Duration Time 0:00
Remaining Time -0:00
Loaded: 0%
Progress: 0%
00:00
Fullscreen
00:00
Mute
view in full page
10 years, 6 months ago

Does personalised medicine require a new business model for healthcare?

Jaume Reventos
Directory:
Cancer
Tags:
biobanks
EUTROC
genetic targets
molecular targets
ovarian cancer
personalized medicine
tissue samples
translational research
tumor banks
tumor profiling
Play
Current Time 0:00
/
Duration Time 0:00
Remaining Time -0:00
Loaded: 0%
Progress: 0%
00:00
Fullscreen
00:00
Mute
view in full page
10 years, 6 months ago

How do you break silos of single-use data and promote cross-disciplinary collaborative research efforts, which are essential for personalised medicine?

Jaume Reventos
Directory:
Cancer
Tags:
disposal
EUTROC
molecular targets
ovarian cancer
personalized medicine
privacy
tissue samples
translational research
tumor banks
tumor profiling
Play
Current Time 0:00
/
Duration Time 0:00
Remaining Time -0:00
Loaded: 0%
Progress: 0%
00:00
Fullscreen
00:00
Mute
view in full page
10 years, 7 months ago

To what extent does personalised medicine require regulatory and legislative change?

Jaume Reventos
Directory:
Cancer
Tags:
cancer research
cancer treatments
data protection
EUTROC
new medical devises
patient data
personalised medicine
regulatory requirements
sperimental drugs
Play
Current Time 0:00
/
Duration Time 0:00
Remaining Time -0:00
Loaded: 0%
Progress: 0%
00:00
Fullscreen
00:00
Mute
view in full page
load more Loading..